Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Immunomodulatory roles of VIP and PACAP in models of multiple sclerosis.

Abad C, Waschek JA.

Curr Pharm Des. 2011;17(10):1025-35. Review.

PMID:
21524252
2.

Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

Gonzalez-Rey E, Varela N, Chorny A, Delgado M.

Curr Pharm Des. 2007;13(11):1113-39. Review.

PMID:
17430175
3.

Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP.

Abad C, Gomariz RP, Waschek JA.

Curr Top Med Chem. 2006;6(2):151-63. Review.

PMID:
16454764
4.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.

Ganea D, Rodriguez R, Delgado M.

Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):127-42. Review.

PMID:
12887096
5.

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.

Baranowska-Bik A, Kochanowski J, Uchman D, Wolinska-Witort E, Kalisz M, Martynska L, Baranowska B, Bik W.

J Neuroimmunol. 2013 Oct 15;263(1-2):159-61. doi: 10.1016/j.jneuroim.2013.08.012. Epub 2013 Aug 30.

PMID:
24041830
8.

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.

Tan YV, Waschek JA.

ASN Neuro. 2011 Oct 6;3(4). pii: e00065. doi: 10.1042/AN20110024. Review.

10.

VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.

Delgado M, Reduta A, Sharma V, Ganea D.

J Leukoc Biol. 2004 Jun;75(6):1122-30. Epub 2004 Mar 12.

PMID:
15020654
11.
13.

Vasoactive intestinal peptide as a healing mediator in Crohn's disease.

Arranz A, Abad C, Juarranz Y, Leceta J, Martinez C, Gomariz RP.

Neuroimmunomodulation. 2008;15(1):46-53. doi: 10.1159/000135623. Epub 2008 Jul 29. Review.

PMID:
18667799
15.

VIP-PACAP system in immunity: new insights for multitarget therapy.

Gomariz RP, Juarranz Y, Abad C, Arranz A, Leceta J, Martinez C.

Ann N Y Acad Sci. 2006 Jul;1070:51-74. Review.

PMID:
16888149
16.
18.

Role of VIP and PACAP in islet function.

Winzell MS, Ahrén B.

Peptides. 2007 Sep;28(9):1805-13. Epub 2007 May 6. Review.

PMID:
17559974
19.
20.

Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis.

Nussdorfer GG, Malendowicz LK.

Peptides. 1998;19(8):1443-67. Review.

PMID:
9809661

Supplemental Content

Support Center